Medical Advisors
Dr. Kiyoshi Kurokawa
KurokawaIndependent Advisor 
Dr. Kurokawa has over 40 years of medical and pharmaceutical experience in the U.S. and Japan. Dr. Kurokawa is one of the most well-known and influential experts in the Japanese pharmaceutical industry today.

Positions Dr. Kurokawa held include:
  • Advisor to the Cabinet of Japan
  • Chair of Special Committee for Drug Evaluation of MHLW (Ministry of Health, Labour, and Welfare, Japan)
  • Chair of MHLW’s Investigation Panel for Anti-cancer and Unapproved Drugs
  • Chair of National Health Policy of MHLW
  • Chair of Committee for Drug Approval & Reimbursement
  • President, Science Council of Japan & Pacific Science Association
  • Member of the Science and Technology Policy Committee of the Cabinet Office

  • Professor, UCLA
  • Professor, the University of Tokyo
  • Professor, National Graduate Institution for Policy Studies
 

Mission

SFJ Pharmaceuticals’® mission is to accelerate the availability of new and innovative drugs into the world’s major markets, by providing not only additional funding, but also strategic development expertise to enable our Pharma and Biotech partners to be as hands off or as hands on as they wish.